tradingkey.logo
tradingkey.logo
Search

SBC Medical Group Holdings Inc

SBC
Add to Watchlist
3.070USD
+0.070+2.33%
Close 06/18, 16:00ETQuotes delayed by 15 min
314.91MMarket Cap
7.73P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
8.67
Change
0
The current earnings forecast score of SBC Medical Group Holdings Inc is 8.67, ranking 13 out of 161 in the Professional & Commercial Services industry. The average price target is 9.00, with a high of 9.00 and a low of 6.50.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
8.500
Target Price
+176.87%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

82
Total
5
Median
9
Average
Company name
Ratings
Analysts
SBC Medical Group Holdings Inc
SBC
3
PayPal Holdings Inc
PYPL
46
Block Inc
XYZ
45
Visa Inc
V
42
Fiserv Ord Shs
FISV
36
Fiserv Inc
FI
36
1
2
3
...
17

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is SBC Medical Group Holdings Inc's expected revenue for the next quarter?

SBC Medical Group Holdings Inc's expected revenue is 45.45M.

What is SBC Medical Group Holdings Inc's price target?

Analysts forecast that SBC Medical Group Holdings Inc's price target is USD 9.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 6.50.

How have SBC Medical Group Holdings IncSBC's recent earnings per share performed?

The market expectation was USD 0.11, while SBC Medical Group Holdings IncSBC's earnings per share (EPS) for the previous quarter was USD 0.14. EPS for the next quarter is expected at USD 0.12.

What is the analyst rating for SBC Medical Group Holdings Inc?

Based on the ratings of SBC Medical Group Holdings Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI